ASCO Coronavirus Resources
As the nation continues to respond to the coronavirus (COVID-19) pandemic, ASCO is committed to providing the most current information and resources to its members and the larger oncology community to help ensure that…
Related Articles
Posters – ESMO Congress 2023
Marwan Fakih (Duarte, United States of America) We have previously reported significant differences between the tumor immune microenvironm ent (TIME) of primary colorectal cancer (CRC-P)…
Tumor Mutational Burden and Outcomes in Patients With Diverse Advanced Cancers Treated With Immunotherapy
This cohort study evaluates tumor mutational burden and outcomes in patients with diverse advanced cancers treated with immunotherapy.
Germline Findings Among Tumors From Cancer Types Lacking Hereditary Testing Guidelines
This cross-sectional study examines the prevalence of germline findings in patients undergoing tumor/normal matched sequencing among cancer types lacking guidelines.
Dual tissue and plasma testing to improve detection of actionable variants in patients with solid cancers.
3017 Background: Next generation sequencing (NGS) of tumor tissue and plasma (circulating tumor DNA [ctDNA]) are used clinically to identify actionable genomic alterations, with implications…
Use of clinical RNA-sequencing in the detection of actionable fusions compared to DNA-sequencing alone.
3077 Background: While targeted DNA-seq can detect clinically actionable fusions in tumor tissue samples, technical and analytical challenges may give rise to false negatives. RNA-based,…
CTG Labs – NCBI
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
CTG Labs – NCBI
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Paper: Phase III Study of Daratumumab/rhuph20 (nsc- 810307) + Lenalidomide or Lenalidomide As Post-Autologous Stem Cell Transplant Maintenance Therapyin Patients with Multiple Myeloma (mm) Using Minimal Residual Disease Todirect Therapy Duration (DRAMMATIC study): SWOG s1803
Program: Oral and Poster Abstracts Session: 731. Clinical Autologous Transplantation: Results: Poster I Hematology Disease Topics & Pathways: Adult, Non-Biological, Therapies, Study Population, Clinically relevant…
Concordance in Molecular Tumor Board Case Reviews in the ASCO TAPUR Study
PURPOSE With the advent of precision medicine, molecular tumor boards (MTBs) were established to interpret genomic results and guide decision making for targeted therapy in…